中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Physiologic Plasticity of Intramyocardial Lipid Storage

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
University Hospital Inselspital, Berne
合作者
Takeda

关键词

抽象

The main goal of the present study was to provide a technical basis for future studies assessing the role of cardiac lipids. More specifically, non-invasive MR-Spectroscopy (MRS) techniques will be used in this study to:
1. assess the methodological reproducibility of MRS-measurements of cardiac lipids in humans
2. investigate physiological variations of cardiac lipids by measuring day-to-day changes under identical conditions
3. determining diurnal variations of cardiac lipids in humans

描述

Background

Obesity is a well known risk factor for the development of glucose intolerance, type 2 diabetes mellitus and, consequently, diabetic complications like cardiovascular disease. Importantly, obesity is not only associated with lipid accumulation in adipose tissue (orthotopic fat deposition), but also in non-adipose tissues (ectopic fat deposition). Clinical studies have repetitively shown that muscular and hepatic lipid accumulation as well as elevated visceral adipose tissue is associated with the development of central and peripheral insulin resistance. In addition, recent data from animal studies show increasing evidence that two other organs, the heart and the pancreas, may also be involved in the pathophysiological processes of reduced insulin sensitivity. While reduced insulin secretion in the course of type 2 diabetes has been well documented, the importance of pancreatic fat deposition as an early step in this process has only recently been suggested based on animal models. Conversely, ischemic heart disease is one of the most dangerous complications of diabetes mellitus, its prevention thereby being a cornerstone of current diabetes management. Recent data suggest that changes in the lipid metabolism of the heart and associated epi- and myocardial lipid deposition may be earliest signs of diabetic cardiopathy.

Magnetic-Resonance-Imaging (MRI) and -Spectroscopy (MRS) are among the most versatile methods for non-invasive studies of human tissue and/or metabolism in vivo and in situ. The excellent soft tissue contrast of MRI has already led to the implementation of this method for the assessment of whole body lipid accumulation, whereas MRS has successfully been applied to study lipid metabolism of skeletal muscle and liver. The extended application of this method towards heart and pancreas will allow a comprehensive investigation of orthotopic and ectopic fat deposition in humans and its association with the development of insulin resistance and diabetes mellitus.

The methodological part of the study will focus on the physiologic plasticity of cardiac lipids in order to assess:

i) methodological reproducibility ii) intra-individual physiological reproducibility by measuring day-to-day variations as well as variations during the day.

Objective

i) Adapting and optimizing the single-voxel MRS sequence that is currently used for muscle and liver, such that respiratory and cardiac double-triggering enables spectroscopy of the cardiac muscle.

ii) Validate the methodology under different standardized physiologic conditions.

Methods

Cardiac lipids are determined during five independent MR-examinations distributed over two days separated by one or two weeks. Both days included a measurement in the morning after an overnight fast (>8h) and one in the afternoon (8h after breakfast, 3.5h after lunch). To determine methodological reproducibility, the afternoon measurement was repeated on one of the two days (1h break). Preparation of the volunteers included perpetuation of their normal diet, but restricted physical activity for two preceding days. Cardiac lipids were determined by single-voxel MR-Spectroscopy.

日期

最后验证: 07/31/2013
首次提交: 08/04/2013
提交的预估入学人数: 08/07/2013
首次发布: 08/12/2013
上次提交的更新: 08/07/2013
最近更新发布: 08/12/2013
实际学习开始日期: 12/31/2009
预计主要完成日期: 11/30/2011
预计完成日期: 11/30/2011

状况或疾病

Lipid Metabolism

干预/治疗

Other: Volunteers

Other: Volunteers

-

手臂组

干预/治疗
Volunteers
young (age<30), healthy, lean (BMI<25) volunteers
Other: Volunteers
normal dietary behavior during examination days

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别Male
取样方式Non-Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- male

- age 18-30

- BMI <25

- healthy

- written informed consent

Exclusion Criteria:

- contraindications to MRI examinations (claustrophobia, implanted devices (pacemaker, insulin pump, neurostimulators))

结果

主要结果指标

1. Intramyocardial lipid content [at baseline (morning of examination day 1)]

次要成果指标

1. Intramyocardial lipid content [evening of examination day 1, i.e. 8 hours after baseline]

2. Intramyocardial lipid content [morning of examination day 2, i.e. 7 days after baseline]

3. Intramyocardial lipid content [evening of examination day 2, i.e. 7 days & 8 hours after baseline]

4. Intra-individual variation of intramyocardial lipid content [evening of examination day one, i.e. 8 hours after baseline]

Difference between evening and morning measurement within examination day one

5. Intra-individual variation of intramyocardial lipid content [evening of examination day two, i.e. 7 days & 8 hours after baseline]

Difference between evening and morning measurement within examination day two

6. Intra-individual difference of intramyocardial lipid content (morning) over one week [morning of examination day one, i.e. 7 days after baseline]

Difference between morning measurements of examination day 1 and examination day 2

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge